Danielle Mercatante Carrick, PhD, MHS

Biography

Danielle Mercatante Carrick, PhD, MHS, is a program director in the Genomic Epidemiology Branch (GEB) of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). She is responsible for managing a research grant portfolio related to cellular and molecular factors that influence personal susceptibility to cancer, including genomics, proteomics, and immune factors. She is the DCCPS biospecimen coordinator, and one of the EGRP Cohort coordinators.

Dr. Carrick is a trained molecular pharmacologist and clinical researcher, with experience conducting epidemiological, biomedical, genetic, and pharmacological research studies focused on cancer, biospecimen science, autoimmune diseases, infectious diseases, immunology, and transfusion medicine. Prior to joining EGRP, she served as co-deputy project director and biospecimen lead for the NCI's Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial and as an Epidemiologist for the National Heart, Lung, and Blood Institute's Retrovirus Epidemiology Donor Study II (REDS-II) at Westat, Inc.

Dr. Carrick completed her postdoctoral training as an Intramural Research Training Award (IRTA) fellow in the Office of Clinical Research at the National Institute of Environmental Health Sciences (NIEHS). She conducted studies to examine potential genetic associations with cancer, autoimmune disorders, asthma, and congenital hydrocephalus; and to develop laboratory tests that measured immune regulator gene expression levels in whole blood and monocytes in response to environmental factors. While at NIEHS, Dr. Carrick was selected to receive training in epidemiology through the NIH-Duke Training Program in Clinical Research.

Select Publications

See listing of articles authored by Dr. Carrick in PubMed.